DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXQ2

Real-time Bid/Ask 12:56:01 2024-06-12 pm EDT
178.19 EUR / 178.27 EUR -1.03% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+1.88%
1 month+1.25%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-12 178.3 -0.99%
24-06-11 180.1 +0.19%
24-06-10 179.7 +0.37%
24-06-07 179.1 +0.74%
24-06-06 177.8 +0.05%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 08:43 am EDT

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXQ
ISINDE000ME7TXQ2
Date issued 2024-01-29
Cap 200 $
Last trading day 2024-12-20
Maturity 2024-12-20 (191 Days)
Parity 1 : 1
Emission price 175.9
Emission volume N/A
Payment day 2024-12-31
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 17.62 %
Sideways yield 3.445 %
Sideways yield pa 6.584 %
Outperformance point 242.8 $
Break even 193.34 €
Highest since issue 180.4
Lowest since issue 172.2
Spread 0.08
Spread %0.04%
Distance Cap 34.87 $
Distance Cap %+14.85%
Max. earning 6.141
Max. earning % 3.445 %

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
234.9 USD
Average target price
278.7 USD
Spread / Average Target
+18.62%
Consensus